WHO ICTRP trial
Splanchnic Blood Volume by Cardiovascular MR as a Novel Marker of Haemodynamic…
DRKS00038214 · German Clinical Trials Register · Recruiting
Key facts
| Trial ID | DRKS00038214 |
|---|---|
| Public title | Splanchnic Blood Volume by Cardiovascular MR as a Novel Marker of Haemodynamic Congestion across the Heart-Failure Spectrum: A Pilot Study |
| Scientific title | Splanchnic Blood Volume by Cardiovascular MR as a Novel Marker of Haemodynamic Congestion across the Heart-Failure Spectrum: A Pilot Study - SPLASH-HF |
| Primary sponsor | Herzzentrum Leipzig |
| Registry | German Clinical Trials Register |
| Recruitment status | Recruiting |
| Study type | observational |
| Countries | Germany |
| Conditions | I50.1;Left ventricular failure |
| Interventions | Group 1: Quantification of splanchnic blood volume among the three predefined cohorts in routine cardiovascular MRI: After detailed verbal information and provision of the written patient-information sheet, written informed consent is… |
| Registration date | Oct 22, 2025 |
| Target size | 24 |
| Secondary IDs | 324/25-ek |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: